Enabled by a new high-resolution mapping technique, the findings overturn a long-held belief that the genome loses its 3D structure when cells divide.

Their system uses electrochemically generated bubbles to detach cells from surfaces, which could accelerate the growth of carbon-absorbing algae and lifesaving cell therapies.

Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.

Speakers at MIT’s Aging Brain Initiative symposium described how immune system factors during aging contribute to Alzheimer’s, Parkinson’s and other conditions. The field is leveraging that knowledge to develop new therapies.

A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.

A leading researcher in protein folding biochemistry and next-generation protein engineering techniques will advance chemistry research and education.

MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.

The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.

The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.

A new study finds over half the drugs approved this century cite government-funded research in their patents.

By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.

Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.

Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.

The method enhances 3D bioprinting capabilities, accelerating process optimization‎ for real-world applications in tissue engineering.

MIT CSAIL researchers developed a tool that can model the shape and movements of fetuses in 3D, potentially assisting doctors in finding abnormalities and making diagnoses.

Cache DNA has developed technologies that can preserve biomolecules at room temperature to make storing and transporting samples less expensive and more reliable.

Advance from SMART will help to better identify disease markers and develop targeted therapies and personalized treatment for diseases such as cancer and antibiotic-resistant infection.

A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.

Tom Zeller’s new book, “The Headache,” sheds light on one of the world’s most confounding and agonizing ailments.

Outfitted with antibodies that guide them to the tumor site, the new nanoparticles could reduce the side effects of treatment.

Professor Caroline Uhler discusses her work at the Schmidt Center, thorny problems in math, and the ongoing quest to understand some of the most complex interactions in biology.

A commitment from longtime supporters Patricia and James Poitras ’63 initiates multidisciplinary efforts to understand and treat complex psychiatric disorders.

VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.

Researchers developed an approach to study where proteins get made, and characterized proteins produced near mitochondria, gaining potential insights into mitochondrial function and disease.

Tools build on years of research at Lincoln Laboratory to develop a rapid brain health screening capability and may also be applicable to civilian settings such as sporting events and medical offices.

By combining several cutting-edge imaging technologies, a new microscope system could enable unprecedentedly deep and precise visualization of metabolic and neuronal activity, potentially even in humans.

Researchers develop a fast-acting, cell-permeable protein system to control CRISPR-Cas9, reducing off-target effects and advancing gene therapy.

The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.

Ianacare, co-founded by Steven Lee ’97, MEng ’98, equips caregivers with the resources, networks, and tools they need to support loved ones.

Researchers developed a tool to recreate cells’ family trees. Comparing cells’ lineages and locations within a tumor provided insights into factors shaping tumor growth.

The mechanical system could be used to deliver drugs in the GI tract or monitor aquatic environments.

The Fairbairn Menstruation Science Fund will allow researchers to accelerate the understanding and treatment of often-neglected diseases that tend to be more common in women.

A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.

The molecules trigger a built-in cellular stress response and show promise as broad-spectrum antivirals against Zika, herpes, RSV, and more.

CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.

CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.

MIT researchers analyzed the nutritional content of millions of menu items across Boston, London, and Dubai.

The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.

Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.

Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.

The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.

Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.

Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.

Scaling up nanoparticle production could help scientists test new cancer treatments.

Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.

When scientists stimulated cells to produce a protein that helps “water bears” survive extreme environments, the tissue showed much less DNA damage after radiation treatment.

Stefani Spranger is working to discover why some cancers don’t respond to immunotherapy, in hopes of making them more vulnerable to it.

When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.

Four professors and an additional alumnus honored with nation’s highest awards for scientists and engineers; Moderna, with deep MIT roots, also recognized.

Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.